Breaking Unvaccinated Woman Dies From Measles Complications in Pennsylvania Tatyana Ali Advocates for Black and Indigenous Maternal Health, Citing Personal Experience Star Trek Celebrates 60 Years Amidst Audience And Adaptation Challenges Experts Detail Psychological Hurdles to Seeking Help, Emphasize It as a Sign of Strength Canadian Woman Escapes ISIS, Becomes Informant Aiding Rescues
Sunday September 13, 2026
86° Houston, TX Clear
Become a Contributor
Section

Business

TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
Press Release

TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial

Longest survival data ever reported in a global Phase III trial in this setting New data reinforce TAGRISSO as the

Business Wire · 11 minutes ago
Read Full Story